MELD+ · Perioperative Risk Brief
Contact: saifeldin676@gmail.com
Response within 2 business days.
MELD 3.0 — adopted by OPTN in 2023, replacing MELD-Na. MELD+ shows both, since many published studies and institutional protocols still reference MELD-Na.
Three reasons: MELD 3.0 adds 1.33 points for female candidates, incorporates albumin, and caps creatinine at 3.0 mg/dL rather than 4.0.
No. Everything runs locally and is discarded when the app closes. See the Privacy Policy.
No. The UNOS section is reference material for perioperative situational awareness. Listing, status assignment, and exception requests go through your transplant program and the NLRB against current OPTN policy at optn.transplant.hrsa.gov.
Email the screen, the inputs used, and the expected value with a citation. Clinical corrections are prioritised over feature requests.